NCT02028455 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^5 CAR T cells/kg
- id
- FG000
- title
- Phase 1 - Cohort 1A
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^6 CAR T cells/kg
- id
- FG001
- title
- Phase 1 - Cohort 1B
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^6 CAR T cells/kg
- id
- FG002
- title
- Phase 1 - Cohort 1C
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^7 CAR T cells/kg
- id
- FG003
- title
- Phase 1 - Cohort 1D
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^5 CAR T cells/kg following prescribed lymphodepletion with fludarabine and cyclophosphamide
- id
- FG004
- title
- Phase 1 - Cohort 1F1
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^6 CAR T cells/kg following prescribed lymphodepletion with fludarabine and cyclophosphamide
- id
- FG005
- title
- Phase 1 - Cohort 1F2
- description
- Phase 1 subjects who were not treated
- id
- FG006
- title
- Phase 1- Not Treated
- description
- The phase 2 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1 x 10\^6 CAR T cells/kg following lymphodepletion if indicated.
- id
- FG007
- title
- Phase 2
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 17
- type
- Went off study without receiving CAR T cell infusion
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 120
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 17
- type
- NOT COMPLETED
- title
- Enrollment and Preliminary Assessments
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 2
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 40
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 3
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 61
- type
- Still in long-term follow up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- NOT COMPLETED
- title
- Treatment(T cell infusion) and Follow up
Complete source fields
- groups
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^5 CAR T cells/kg
- id
- FG000
- title
- Phase 1 - Cohort 1A
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^6 CAR T cells/kg
- id
- FG001
- title
- Phase 1 - Cohort 1B
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^6 CAR T cells/kg
- id
- FG002
- title
- Phase 1 - Cohort 1C
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^7 CAR T cells/kg
- id
- FG003
- title
- Phase 1 - Cohort 1D
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 5x10\^5 CAR T cells/kg following prescribed lymphodepletion with fludarabine and cyclophosphamide
- id
- FG004
- title
- Phase 1 - Cohort 1F1
- description
- This phase 1 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1x10\^6 CAR T cells/kg following prescribed lymphodepletion with fludarabine and cyclophosphamide
- id
- FG005
- title
- Phase 1 - Cohort 1F2
- description
- Phase 1 subjects who were not treated
- id
- FG006
- title
- Phase 1- Not Treated
- description
- The phase 2 cohort received Patient Derived CD19 specific CAR T cells at a dose of 1 x 10\^6 CAR T cells/kg following lymphodepletion if indicated.
- id
- FG007
- title
- Phase 2
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 17
- type
- Went off study without receiving CAR T cell infusion
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 120
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 4
- group Id
- FG007
- num Subjects
- 17
- type
- NOT COMPLETED
- title
- Enrollment and Preliminary Assessments
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 4
- group Id
- FG001
- num Subjects
- 9
- group Id
- FG002
- num Subjects
- 3
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 2
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 40
- type
- Death
- reasons
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 1
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 2
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 3
- group Id
- FG001
- num Subjects
- 3
- group Id
- FG002
- num Subjects
- 4
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 3
- group Id
- FG005
- num Subjects
- 3
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 61
- type
- Still in long-term follow up
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 0
- group Id
- FG001
- num Subjects
- 0
- group Id
- FG002
- num Subjects
- 0
- group Id
- FG003
- num Subjects
- 0
- group Id
- FG004
- num Subjects
- 0
- group Id
- FG005
- num Subjects
- 0
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 0
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 7
- group Id
- FG001
- num Subjects
- 12
- group Id
- FG002
- num Subjects
- 7
- group Id
- FG003
- num Subjects
- 5
- group Id
- FG004
- num Subjects
- 6
- group Id
- FG005
- num Subjects
- 6
- group Id
- FG006
- num Subjects
- 0
- group Id
- FG007
- num Subjects
- 103
- type
- NOT COMPLETED
- title
- Treatment(T cell infusion) and Follow up
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle